可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Fukushima H, Sugiyama S, Honda O, et al. Prognostic value of remnantlike lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus[J]. J Am Coll Cardiol,2004,43(12):2219-2224.
[2] von Muhlen D, Langer RD, BarrettConnor E. Sex and time differences in the associations of non-highdensity lipoprotein cholesterol versus other lipid and lipoprotein factors in the prediction of cardiovascular death (The Rancho Bernardo Study)[J]. Am J Cardiol, 2003,91(11):1311-1315.
[3] Castanho VS, Oliveira LS, Pinheiro HP, et al. Sex differences in risk factors for coronary heart disease: a study in a Brazilian population[J]. BMC Public Health, 2001,1(1):3.
[4] Ford ES, Mokdad AH, Giles WH, et al. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000[J]. Circulation, 2003,107(17):2185-2189.
[5]Nielsen NE, Olsson AG, Swahn E. Plasma lipoprotein particle concentrations in postmenopausal women with unstable coronary artery disease. Analysis of diagnostic accuracy using receiver operating characteristics[J]. J Intern Med, 2000,247(1):43-52.
[6]Ballantyne CM, Andrews TC, Hsia JA, et al. Correlation of nonhighdensity lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on nonhighdensity lipoprotein cholesterol levels[J]. Am J Cardiol, 2001,88(3):265-269.